BACKGROUND: Coronary flow reserve (CFR) in the left anterior descending artery (LAD) can be reduced in nonischemic dilated cardiomyopathy (DCM). The aim of this study was to assess the prognostic value of CFR in LAD and in the posterior descending artery (PD) in DCM patients. METHODS: Seventy-two DCM patients (44 men, mean age 64 ± 13 years) underwent dipyridamole (0.84 mg/kg in 6 minutes) stress echo. CFR was defined as the ratio between maximal vasodilation and rest peak diastolic flow velocity in LAD and PD. RESULTS: CFR was abnormal in LAD in 42 out of 72 patients and in PD in 31 out of 55. All patients completed the clinical follow-up, and 56 patients completed the echocardiographic follow-up. During median follow-up of 42 months, 33 events (7 deaths, 26 major cardiac events) occurred. Event rate was markedly higher for patients with reduced CFR compared with DCM patients with normal CRF in LAD (0 vs 19 events; P < .001) and in PD (1 vs 13 events; P < .001). CFR in LAD and in PD were significantly related to the change in end-systolic volume during follow-up (r = -0.481, P < .001; and r = -0.407, P = .028; respectively). Preserved CFR in both LAD and PD was associated with better (P < .0001) event-free survival compared with abnormal CFR (log rank: 28.1; P < .0001). CONCLUSIONS: In DCM patients, impairment of CFR in LAD and PD is related to a worse outcome; CFR impairment is more relevant when it occurs in LAD. PD evaluation may be redundant and time-consuming, because the additive value is small and the feasibility suboptimal.
BACKGROUND: Coronary flow reserve (CFR) in the left anterior descending artery (LAD) can be reduced in nonischemic dilated cardiomyopathy (DCM). The aim of this study was to assess the prognostic value of CFR in LAD and in the posterior descending artery (PD) in DCMpatients. METHODS: Seventy-two DCMpatients (44 men, mean age 64 ± 13 years) underwent dipyridamole (0.84 mg/kg in 6 minutes) stress echo. CFR was defined as the ratio between maximal vasodilation and rest peak diastolic flow velocity in LAD and PD. RESULTS: CFR was abnormal in LAD in 42 out of 72 patients and in PD in 31 out of 55. All patients completed the clinical follow-up, and 56 patients completed the echocardiographic follow-up. During median follow-up of 42 months, 33 events (7 deaths, 26 major cardiac events) occurred. Event rate was markedly higher for patients with reduced CFR compared with DCMpatients with normal CRF in LAD (0 vs 19 events; P < .001) and in PD (1 vs 13 events; P < .001). CFR in LAD and in PD were significantly related to the change in end-systolic volume during follow-up (r = -0.481, P < .001; and r = -0.407, P = .028; respectively). Preserved CFR in both LAD and PD was associated with better (P < .0001) event-free survival compared with abnormal CFR (log rank: 28.1; P < .0001). CONCLUSIONS: In DCMpatients, impairment of CFR in LAD and PD is related to a worse outcome; CFR impairment is more relevant when it occurs in LAD. PD evaluation may be redundant and time-consuming, because the additive value is small and the feasibility suboptimal.
Authors: Maulik D Majmudar; Venkatesh L Murthy; Ravi V Shah; Swathy Kolli; Negareh Mousavi; Courtney R Foster; Jon Hainer; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Lynne W Stevenson; Mandeep R Mehra; Marcelo F Di Carli Journal: Eur Heart J Cardiovasc Imaging Date: 2015-02-25 Impact factor: 6.875
Authors: Li-Ming Gan; Sara Svedlund; Ann Wittfeldt; Charlotte Eklund; Sinsia Gao; Göran Matejka; Anders Jeppsson; Per Albertsson; Elmir Omerovic; Amir Lerman Journal: J Am Heart Assoc Date: 2017-04-18 Impact factor: 5.501
Authors: Mihir A Kelshiker; Henry Seligman; James P Howard; Haseeb Rahman; Michael Foley; Alexandra N Nowbar; Christopher A Rajkumar; Matthew J Shun-Shin; Yousif Ahmad; Sayan Sen; Rasha Al-Lamee; Ricardo Petraco Journal: Eur Heart J Date: 2022-04-19 Impact factor: 35.855
Authors: David Corcoran; Aleksandra Radjenovic; Ify R Mordi; Sheraz A Nazir; Simon J Wilson; Markus Hinder; Denise P Yates; Surendra Machineni; Jose Alcantara; Margaret F Prescott; Barbara Gugliotta; Yinuo Pang; Niko Tzemos; Scott I Semple; David E Newby; Gerry P McCann; Iain Squire; Colin Berry Journal: Cardiovasc Res Date: 2021-01-01 Impact factor: 10.787